BACKGROUND: Brain imaging studies of early Alzheimer's disease (AD) have shown
decreased metabolism predominantly in the posterior cingulate cortex (PCC), medial temporal …

The introduction of fast scintillators with good stopping power for 511-keV photons has
renewed interest in time-of-flight (TOF) PET. The ability to measure the difference between the …

The potential of positron emission tomography (PET) to distinguish benign from malignant
ovarian tissue was evaluated by comparing the results of F-18 fluoro-2-D-deoxyglucose (F-18-…

PET and 18 F-FDG have the potential to follow the early metabolic response to chemotherapy
in patients with non–small cell lung cancer and to predict success or failure of the therapy. …

PURPOSE: To investigate the role of 18-fluorine-fluorodeoxyglucose positron emission
tomography/computerized tomography ( 18 F-FDG PET/CT) in the preoperative prediction of the …

BNCT as a treatment for glioblastoma multiforme and melanoma. Successful BNCT depends
on knowledge of the distribution of boron-containing agents in both tumor and normal …

Fluorine-18 labeled deoxyglucose positron-emission tomography (FDG-PET) applications
in oncology include the differential diagnosis of chest masses and single pulmonary nodules. …

RESULTS General for whole group. Table 1 gives a con densed summary of the total data
bank on which this report is based. Each area of known or suspected lesion was considered …

A meta-analysis of data primarily from PET oncologic investigations using FDG PET was
performed. Its purpose was to establish statistical features of the distributions of standardized …

Purpose: The potential for improving the diagnostic performance of static positron imaging
tomography (PET) by judiciously choosing optimum post-injection imaging times is …